Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PROF
12076
PUT
Profound Medical
PROF
$222M
| $39.8K | ﹤0.01% |
+5,000
| New | +$45.2K |
2024 Q3
0 quarters
|
|
12077
PUT
Senseonics Holdings Inc
SENS
$527M
| $39.6K | ﹤0.01% |
5,665
+2,620
| +86% | +$21.1K |
2020 Q3
16 quarters
|
|
|
GRTS
12078
CALL
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $39.6K | ﹤0.01% |
68,300
+33,700
| +97% | +$18.9K |
2021 Q1
14 quarters
|
|
12079
ProShares Ultra Yen
YCL
$29.9M
| $39.6K | ﹤0.01% |
+1,603
| New | +$37.6K |
2024 Q3
0 quarters
|
|
12080
FuelCell Energy
FCEL
$1.65B
| $39.6K | ﹤0.01% |
3,471
-10,330
| -75% | -$153K |
2020 Q1
18 quarters
|
|
|
FTH
12081
Faeth Therapeutics
FTH
$695M
| $39.5K | ﹤0.01% |
3,302
+2,534
| +330% | +$30.9K |
2023 Q4
3 quarters
|
|
12082
PUT
Ceco Environmental
CECO
$4.42B
| $39.5K | ﹤0.01% |
1,400
-5,800
| -81% | -$163K |
2022 Q4
7 quarters
|
|
12083
CALL
Matthews International
MATW
$606M
| $39.4K | ﹤0.01% |
1,700
-2,400
| -59% | -$60.5K |
2022 Q4
7 quarters
|
|
12084
CALL
Invesco MSCI Global Timber ETF
CUT
$28.9M
| $39.3K | ﹤0.01% |
+1,100
| New | +$37.1K |
2024 Q3
0 quarters
|
|
12085
PUT
Adeia
ADEA
$2.71B
| $39.3K | ﹤0.01% |
+3,300
| New | +$38.3K |
2024 Q3
0 quarters
|
|
|
FLZH
12086
DELISTED
FLASH SPORTS & MEDIA HLDG
FLZH
| $39.3K | ﹤0.01% |
1,138
+191
| +20% | +$6.66K |
2023 Q4
3 quarters
|
|
|
DRK
12087
CALL
DarkHorse Technologies Inc. Common Shares
DRK
$29.4M
| $39.3K | ﹤0.01% |
4,340
+1,260
| +41% | +$12K |
2021 Q3
12 quarters
|
|
|
NKLA
12088
DELISTED
Nikola Corporation Common Stock
NKLA
| $39.2K | ﹤0.01% |
8,561
+7,156
| +509% | +$53K |
2020 Q4
15 quarters
|
|
12089
CALL
Cerus
CERS
$472M
| $39.1K | ﹤0.01% |
22,500
+15,300
| +213% | +$32.1K |
2020 Q1
18 quarters
|
|
12090
PUT
Choice Hotels
CHH
$4.64B
| $39.1K | ﹤0.01% |
300
-1,600
| -84% | -$200K |
2021 Q2
13 quarters
|
|
12091
Beyond Air
XAIR
$2.51M
| $39.1K | ﹤0.01% |
252
+104
| +70% | +$20K |
2020 Q4
15 quarters
|
|
12092
Entera Bio
ENTX
$440M
| $39.1K | ﹤0.01% |
+20,553
| New | +$36.5K |
2024 Q3
0 quarters
|
|
12093
PUT
BBB Foods
TBBB
$6.54B
| $39K | ﹤0.01% |
1,300
-800
| -38% | -$22.4K |
2024 Q1
2 quarters
|
|
12094
PUT
Old Republic International
ORI
$9.18B
| $39K | ﹤0.01% |
1,100
-1,300
| -54% | -$44K |
2021 Q1
14 quarters
|
|
12095
Nexalin Technology
NXL
$3.73M
| $38.9K | ﹤0.01% |
+1,940
| New | +$60K |
2024 Q3
0 quarters
|
|
|
KE
12096
CALL
Kimball Electronics
KE
$691M
| $38.9K | ﹤0.01% |
2,100
+1,400
| +200% | +$28K |
2022 Q4
7 quarters
|
|
|
SLI
12097
PUT
Standard Lithium
SLI
$427M
| $38.8K | ﹤0.01% |
24,100
-34,500
| -59% | -$44.4K |
2021 Q3
12 quarters
|
|
12098
PUT
Ultrapar
UGP
$8.25B
| $38.8K | ﹤0.01% |
10,000
+7,800
| +355% | +$32.1K |
2024 Q1
2 quarters
|
|
12099
Alpha Tau Medical
DRTS
$1.34B
| $38.8K | ﹤0.01% |
+16,301
| New | +$36.1K |
2024 Q3
0 quarters
|
|
12100
PUT
Perspective Therapeutics
CATX
$269M
| $38.7K | ﹤0.01% |
+2,900
| New | +$38.6K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.